RCAN3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.520400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.176600E-01
Normal-vs-Stage2
2.192400E-01
Normal-vs-Stage3
8.613700E-02
Normal-vs-Stage4
6.627200E-01
Stage1-vs-Stage2
2.476600E-01
Stage1-vs-Stage3
1.140830E-01
Stage1-vs-Stage4
4.124600E-01
Stage2-vs-Stage3
2.655600E-01
Stage2-vs-Stage4
2.943400E-01
Stage3-vs-Stage4
1.430380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.424200E-01
Normal-vs-AfricanAmerican
9.886200E-01
Normal-vs-Asian
2.900800E-01
Caucasian-vs-AfricanAmerican
1.806020E-01
Caucasian-vs-Asian
4.493400E-01
AfricanAmerican-vs-Asian
2.053600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.868230E-01
Normal-vs-Female
5.358800E-01
Male-vs-Female
2.045800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.659600E-01
Normal-vs-Age(41-60Yrs)
5.478200E-01
Normal-vs-Age(61-80Yrs)
3.349600E-01
Normal-vs-Age(81-100Yrs)
1.886320E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.526200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.854200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.405620E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.107200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.801700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.222200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.638400E-01
Normal-vs-Daily Drinker
9.597800E-02
Normal-vs-Weekly Drinker
5.278200E-02
Normal-vs-Occasional Drinker
9.344000E-01
Normal-vs-Social Drinker
5.352400E-01
Non Drinker-vs-Daily Drinker
6.325800E-01
Non Drinker-vs-Weekly Drinker
1.869210E-01
Non Drinker-vs-Occasional Drinker
1.647800E-01
Non Drinker-vs-Social Drinker
4.061400E-01
Daily Drinker-vs-Weekly Drinker
3.616200E-01
Daily Drinker-vs-Occasional Drinker
1.082370E-01
Daily Drinker-vs-Social Drinker
2.618400E-01
Weekly Drinker-vs-Occasional Drinker
4.267800E-02
Weekly Drinker-vs-Social Drinker
1.160040E-01
Occasional Drinker-vs-Social Drinker
4.905200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.421650E-01
Normal-vs-Grade 2
1.481620E-02
Normal-vs-Grade 3
2.358800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.024800E-01
Grade 1-vs-Grade 3
6.933400E-01
Grade 1-vs-Grade 4
1.421650E-01
Grade 2-vs-Grade 3
9.729600E-01
Grade 2-vs-Grade 4
1.481620E-02
Grade 3-vs-Grade 4
2.358800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.524600E-01
Normal-vs-NonDiabetic
3.099600E-01
Diabetic-vs-NonDiabetic
9.229800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.473700E-02
Normal-vs-NoPancreatitis
3.513400E-01
Pancreatitis-vs-NoPancreatitis
4.251600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.358200E-01
Normal-vs-N1
2.242800E-01
N0-vs-N1
2.687400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.014600E-01
Normal-vs-TP53-NonMutant
6.320600E-01
TP53-Mutant-vs-TP53-NonMutant
9.143200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
